Фекальный кальпротектин — новый количественный биомаркер острой и хронической реакции «Трансплантат против хозяина» с вовлечением кишечника после аллогенной трансплантации гемопоэтических стволовых клеток
Oleg Valerievich Goloshchapov, В. Н. Вавилов, Л С Зубаровская et al. · Клиническая онкогематология. Фундаментальные исследования и клиническая практика · 2011
Aim. To assess the role of fecal calprotectin (FC) as a biomarker for early diagnosis of gut acute and chronic «graft versus host disease» (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) Methods. After allo-HSCT 46 patients were investigated the level of FC was estimated in 171 stool samples. For FC assay IFA method was used by Human Calprotectin ELISA kit (Hycult biotech) Results. The level of FC was higher in patients with gut acute and chronic GVHD, median of FC level (n = 18) at the moment of diagnosis was 210.5 (4.0-653.9) ftg/g. In patients with another reasons of diarrhea (n = 16) median of FC level was 1.0 x 109/L median of FC level was 7.7 (4.0-72.7) ftg/g with reduction < 4fig/g. Correlation between stool volume and level of FC was r = 0.76 (p < 0.01) Specificity of method 100 %, sensibility83.3 % Conclusion. Fecal calprotectin may be a quantity biomarker of acute and chronic GVHD with involvement of gut to be used for diagnosis and correction of immunosuppressive therapy of these complications
Cited by 0 works.